Nintedanib
Nintedanib is a potent small molecule triple angiokinase inhibitor targeting VEGFR, FGFR, and PDGFR receptors. It exhibits anti-angiogenic and anti-tumor activity, validated in both in vitro assays and in vivo models of cancer and fibrotic diseases.
Product Specifications
CAS Number
656247-17-5
Product Name Alternative
BIBF-1120
Field of Research
Cardiovascular Research
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to 4 mg/ml)
Smiles
COC (c1cc2c (/C (C (N2) =O) =C (c3ccccc3) /Nc4ccc (N (C (CN5CCN (CC5) C) =O) C) cc4) cc1) =O
Molecular Formula
C31H33N5O4
Molecular Weight
539.6
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
(3Z) -2,3-Dihydro-3-[[[4-[methyl[2- (4-methyl-1-piperazinyl) acetyl]amino]phenyl]-amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid, methyl ester
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog